Proven Process said today that it’s partnering with PathMaker Neurosystems, a clinical-stage neuromodulation company, to develop and manufacture a device for treating patients with muscle tone disorders using trans-spinal direct current stimulation. Trans-spinal direct current stimulation is a novel form of non-invasive neurostim, Mansfield, Mass.-based Proven Process said. The spinal stimulation uses a direct current to stimulate […]
Pain Management
Boston Scientific touts positive data from next-gen SCS
Boston Scientific (NYSE:BSX) said yesterday that data from its Precision Spectra spinal cord stimulator study showed 1.5 times better pain relief and 2 times better lower back pain relief than its previous generation SCS. The analysis examined 213 patients treated with the new Precision Spectra and 130 patients treated with the previous generation Precision Plus, as well as 25 patients […]
St. Jude Medical touts early results for Axium neurostim device
St. Jude Medical (NYSE:STJ) said Monday that a study of its Axium dorsal root ganglion neurostimulator showed superior pain relief compared to traditional spinal cord stimulation in treating chronic lower limb pain associated with complex regional pain syndrome. The the 152-patient Accurate study reported that 81.2% of patients treated with the Axium system achieved significant pain […]
Stimwave wins nod from FDA for IDE trial
Stimwave Technologies said yesterday it won FDA investigational device exemption clearance to test an 8-electrode version of its wireless miniature neurostimulator device for the relief of chronic back and leg pain. Miami, Fl.-based Stimwave said the FDA also approved a study of the device using high frequency treatments through an external pulse generator. “This study […]
St. Jude, Boston Scientific tout European advances for SCS systems
St. Jude Medical (NYSE:STJ) and Boston Scientific (NYSE:BSX) are touting new developments in Europe for their spinal cord stimulation systems. St. Paul, Minn.-based St. Jude said it won CE Mark approval in the European Union for its Invisible Trial app-based wireless neuromodulation system, the company said. The system leverages Apple (NSDQ:AAPL) iOS devices, specifically an iPod touch for […]
NeuroMetrix raises $14.7m
NeuroMetrix (NSDQ:NURO) said last week that it raised $14.7 million in its most recent funding round. Waltham, Mass.-based NeuroMetrix said it sold 147,000 shares at $100 per share and repurchased all of the outstanding shares of its Series A-4 convertible preferred stock for approximately $3.2 million. The proceeds are slated to be used to fund the commercial […]